Workflow
Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer
BMYBristol-Myers Squibb(BMY) Businesswire·2024-02-23 19:59

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that its previously announced tender offer (the “Offer”) to acquire all of the outstanding shares of RayzeBio, Inc. (Nasdaq: RYZB) common stock for a purchase price of 62.50pershareincash,orapproximately62.50 per share in cash, or approximately 4.1 billion, expired at one minute after 11:59 p.m., Eastern Time, on February 22, 2024 (the “Expiration Time”). Equiniti Trust Company, the depositary for the Offer, has advised that, as of the Expiration Time, appr ...